HomeNewsBusinessPersonal FinanceGovt keeps interest rates on small savings schemes unchanged for 3rd quarter of FY'22

Govt keeps interest rates on small savings schemes unchanged for 3rd quarter of FY'22

Public Provident Fund (PPF) and National Savings Certificate (NSC) will continue to carry an annual interest rate of 7.1 per cent and 6.8 per cent, respectively.

September 30, 2021 / 19:00 IST
Story continues below Advertisement
(Source: ShutterStock)
(Source: ShutterStock)

The government on Thursday kept the interest rates on small savings schemes, including NSC and PPF, unchanged for the third quarter of 2021-22 amid the COVID-19 pandemic and elevated level of inflation. Public Provident Fund (PPF) and National Savings Certificate (NSC) will continue to carry an annual interest rate of 7.1 per cent and 6.8 per cent, respectively.

"The rates of interest on various small savings schemes for the third quarter of the financial year 2021-22 starting from October 1, 2021, and ending on December 31, 2021, shall remain unchanged from the current rates applicable for the second quarter (June 1, 2021 to September 30, 2021) for FY 2021-22," the finance ministry said in a notification. According to analysts, the upcoming Uttar Pradesh assembly elections may also have been a factor behind the government's decision to keep rates unchanged.

Story continues below Advertisement

ALSO READ: Despite government’s U-Turn on small saving interest rates, don’t rush for PPF before April 5

Uttar Pradesh is the second highest contributor to the small savings schemes after West Bengal. During the West Bengal assembly elections earlier this year, the Centre decided to reduce the interest rate on these schemes. However, the very next day on April 1, the finance ministry revoked the steep interest rate cut of up to 1.1 per cent, citing an oversight.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show